News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
552,536 Results
Type
Article (32873)
Company Profile (145)
Press Release (519518)
Multimedia
Podcasts (76)
Webinars (12)
Section
Business (166900)
Career Advice (1469)
Deals (29718)
Drug Delivery (91)
Drug Development (63756)
Employer Resources (110)
FDA (11959)
Job Trends (12021)
News (279508)
Policy (27047)
Tag
Academia (2236)
Academic (1)
Accelerated approval (7)
Adcomms (17)
Allergies (67)
Alliances (41377)
ALS (91)
Alzheimer's disease (1061)
Antibody-drug conjugate (ADC) (104)
Approvals (12014)
Artificial intelligence (230)
Autoimmune disease (22)
Automation (10)
Bankruptcy (261)
Best Places to Work (9154)
BIOSECURE Act (20)
Biosimilars (101)
Biotechnology (75)
Bladder cancer (57)
Brain cancer (28)
Breast cancer (259)
Cancer (2033)
Cardiovascular disease (168)
Career advice (1245)
Career pathing (22)
CAR-T (111)
CDC (25)
Cell therapy (311)
Cervical cancer (21)
Clinical research (53105)
Collaboration (735)
Compensation (384)
Complete response letters (20)
COVID-19 (2208)
CRISPR (47)
C-suite (279)
Cystic fibrosis (91)
Data (2186)
Decentralized trials (1)
Denatured (22)
Depression (38)
Diabetes (248)
Diagnostics (4680)
Digital health (16)
Diversity (5)
Diversity, equity & inclusion (32)
Drug discovery (102)
Drug pricing (110)
Drug shortages (29)
Duchenne muscular dystrophy (88)
Earnings (66745)
Editorial (31)
Employer branding (14)
Employer resources (100)
Events (83394)
Executive appointments (744)
FDA (13166)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (2)
Frontotemporal dementia (7)
Funding (703)
Gene editing (86)
Generative AI (16)
Gene therapy (259)
GLP-1 (628)
Government (3850)
Grass and pollen (4)
Guidances (147)
Healthcare (14237)
HIV (36)
Huntington's disease (15)
IgA nephropathy (33)
Immunology and inflammation (98)
Immuno-oncology (8)
Indications (30)
Infectious disease (2327)
Inflammatory bowel disease (111)
Inflation Reduction Act (9)
Influenza (39)
Intellectual property (84)
Interviews (229)
IPO (13174)
IRA (39)
Job creations (3210)
Job search strategy (1098)
Kidney cancer (11)
Labor market (30)
Layoffs (338)
Leadership (14)
Legal (6695)
Liver cancer (54)
Longevity (9)
Lung cancer (289)
Lymphoma (149)
Machine learning (8)
Management (40)
Manufacturing (317)
MASH (81)
Medical device (8337)
Medtech (8340)
Mergers & acquisitions (17097)
Metabolic disorders (627)
Multiple sclerosis (74)
NASH (21)
Neurodegenerative disease (71)
Neuropsychiatric disorders (15)
Neuroscience (1551)
NextGen: Class of 2025 (5170)
Non-profit (3923)
Now hiring (18)
Obesity (307)
Opinion (180)
Ovarian cancer (62)
Pain (100)
Pancreatic cancer (72)
Parkinson's disease (117)
Partnered (19)
Patents (203)
Patient recruitment (121)
Peanut (28)
People (50983)
Pharmaceutical (70)
Pharmacy benefit managers (19)
Phase I (15057)
Phase II (23201)
Phase III (18831)
Pipeline (1317)
Policy (181)
Postmarket research (2127)
Preclinical (6132)
Press Release (72)
Prostate cancer (104)
Psychedelics (26)
Radiopharmaceuticals (196)
Rare diseases (365)
Real estate (5097)
Recruiting (40)
Regulatory (18491)
Reports (30)
Research institute (2028)
Resumes & cover letters (202)
Rett syndrome (9)
RNA editing (6)
RSV (29)
Schizophrenia (73)
Series A (115)
Series B (73)
Service/supplier (7)
Sickle cell disease (48)
Special edition (10)
Spinal muscular atrophy (119)
Sponsored (22)
Startups (2864)
State (2)
Stomach cancer (8)
Supply chain (58)
Tariffs (54)
The Weekly (52)
Vaccines (594)
Venture capital (34)
Weight loss (189)
Women's health (30)
Worklife (10)
Date
Today (63)
Last 7 days (264)
Last 30 days (1327)
Last 365 days (22881)
2025 (12336)
2024 (26053)
2023 (30118)
2022 (40374)
2021 (43734)
2020 (42754)
2019 (37253)
2018 (28394)
2017 (26068)
2016 (25669)
2015 (30476)
2014 (24302)
2013 (20373)
2012 (21794)
2011 (22719)
2010 (20651)
Location
Africa (662)
Alabama (33)
Alaska (5)
Arizona (156)
Arkansas (10)
Asia (38462)
Australia (5143)
California (4965)
Canada (1965)
China (706)
Colorado (222)
Connecticut (212)
Delaware (128)
Europe (72378)
Florida (846)
Georgia (155)
Hawaii (1)
Idaho (51)
Illinois (456)
India (25)
Indiana (258)
Iowa (10)
Japan (211)
Kansas (89)
Kentucky (28)
Louisiana (14)
Maine (56)
Maryland (787)
Massachusetts (3856)
Michigan (174)
Minnesota (292)
Mississippi (3)
Missouri (71)
Montana (19)
Nebraska (20)
Nevada (65)
New Hampshire (33)
New Jersey (1678)
New Mexico (22)
New York (1494)
North Carolina (798)
North Dakota (5)
Northern California (2161)
Ohio (169)
Oklahoma (13)
Oregon (24)
Pennsylvania (1100)
Puerto Rico (11)
Rhode Island (20)
South America (947)
South Carolina (25)
South Dakota (1)
Southern California (1958)
Tennessee (108)
Texas (764)
United States (19484)
Utah (131)
Virginia (166)
Washington D.C. (57)
Washington State (423)
West Virginia (3)
Wisconsin (64)
552,536 Results for "china national pharmaceutical group corp".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Government
FDA Freezes Trials Shipping Cells to China, ‘Other Hostile Countries’
Exemptions to new export control policies have allowed companies to ship patients’ biological materials to foreign laboratories, including those in China and other adversarial nations, according to the FDA.
June 20, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Brii Biosciences Announces Licensing Agreement with Joincare Group for Rights to BRII-693 in Greater China
July 4, 2025
·
5 min read
Antibody-drug conjugate (ADC)
NextCure Joins China-ADC Gold Rush with $745M Simcere Deal
The deal gets NextCure the rights to Simcere’s novel ADC for solid tumors outside of China.
June 16, 2025
·
1 min read
·
Dan Samorodnitsky
Artificial intelligence
AstraZeneca Makes $5.3B AI Bet With China’s CSPC for Chronic Disease Pills
Friday’s deal with CSPC fits neatly within AstraZeneca’s business development strategy of upping investments in AI and in China.
June 13, 2025
·
2 min read
·
Tristan Manalac
Tariffs
China Still Go-To Source for New Drugs Despite Tariff Minefield
Policy uncertainties are impacting biopharma dealmaking from continent to continent, with companies being asked to walk a tightrope on their relations with China.
April 30, 2025
·
10 min read
·
Annalee Armstrong
Podcast
Pfizer’s $6B China Deal, Drug Pricing and FDA’s New COVID Vaccine Plan
China continues to be a source of innovation as Pfizer strikes biggest pact yet; HHS provides more info on Trump’s Most Favored Nation executive order; FDA Commissioner Marty Makary and CBER director Vinay Prasad reveal new COVID-19 vaccine strategy following Novavax approval; ODAC underway after chaotic planning; more.
May 21, 2025
·
2 min read
·
Heather McKenzie
Press Releases
Connect Biopharma’s Exclusive Licensee in China, Simcere Pharmaceutical, Announced Submission of its New Drug Application for Rademikibart for the Treatment of Atopic Dermatitis in China
July 10, 2025
·
7 min read
Press Releases
Corvus Pharmaceuticals Announces Partner Angel Pharmaceuticals Received IND Approval for a Phase 1b/2 Clinical Trial of Soquelitinib in China for the Treatment of Atopic Dermatitis
June 25, 2025
·
6 min read
Press Releases
KRTL Holding Group Announces KRTL Biotech Inc. Signs MOU with Industria Químico Farmacéutica Sigma Corp. S.R.L. to Pursue Strategic International Merger
March 25, 2025
·
3 min read
Legal
Medical Groups Sue RFK Jr. Over ‘Baseless and Uninformed’ Changes to COVID-19 Vaccine Policy
Societies, including the American Academy of Pediatrics, allege that Kennedy’s directive to remove COVID-19 from vaccination guidelines for healthy pregnant women and healthy children puts these vulnerable groups at risk of serious illness.
July 8, 2025
·
2 min read
·
Tristan Manalac
1 of 55,254
Next
